Contec Medical Systems Co.,Ltd (SHE:300869)
China
· Delayed Price · Currency is CNY 12.76
+0.01 (0.08%)
Apr 24, 2025, 2:45 PM CST
SHE:300869 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Net Income | -19.45 | 165.77 | 196.2 | 352.35 | 613.4 | 73.78 | Upgrade
|
| Depreciation & Amortization | 27.38 | 27.38 | 20.59 | 17.86 | 15.17 | 5.02 | Upgrade
|
| Other Amortization | 0.15 | 0.15 | - | - | 0.86 | 0.86 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.07 | 0.07 | 0.26 | 0.04 | 0 | -0 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 0.01 | 10.72 | 3.76 | 10.58 | Upgrade
|
| Loss (Gain) From Sale of Investments | -13.49 | -13.49 | -54.6 | -1.58 | -0.17 | - | Upgrade
|
| Provision & Write-off of Bad Debts | -1.03 | -1.03 | 2.02 | 0.38 | 1.04 | 1.24 | Upgrade
|
| Other Operating Activities | 75.39 | 32.7 | -40.98 | -115.35 | -0.42 | -12.44 | Upgrade
|
| Change in Accounts Receivable | 148.68 | 148.68 | -64.49 | -23.01 | -56.23 | -24.92 | Upgrade
|
| Change in Inventory | -85.05 | -85.05 | -17.39 | -144.98 | -167.96 | -18.87 | Upgrade
|
| Change in Accounts Payable | -78.3 | -78.3 | 59.34 | -93.11 | 189.72 | 13.6 | Upgrade
|
| Operating Cash Flow | 38.49 | 181.01 | 103.66 | 4.65 | 597.73 | 50.22 | Upgrade
|
| Operating Cash Flow Growth | -82.04% | 74.63% | 2130.42% | -99.22% | 1090.27% | 68.48% | Upgrade
|
| Capital Expenditures | -29.1 | -30.74 | -81.45 | -106.31 | -88.67 | -7.43 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.41 | 0.11 | 0.25 | 0.12 | 0.01 | 0.02 | Upgrade
|
| Investment in Securities | -91.27 | -800 | -50 | 50 | -230 | -24.6 | Upgrade
|
| Other Investing Activities | 522.33 | 107.67 | 17.37 | 5.09 | 3.81 | 6.12 | Upgrade
|
| Investing Cash Flow | 402.38 | -722.96 | -113.82 | -51.09 | -314.85 | -25.89 | Upgrade
|
| Short-Term Debt Issued | - | 632.88 | 874.88 | 915.2 | 262.84 | 18.76 | Upgrade
|
| Long-Term Debt Issued | - | - | 690.1 | - | - | - | Upgrade
|
| Total Debt Issued | 90 | 632.88 | 1,565 | 915.2 | 262.84 | 18.76 | Upgrade
|
| Short-Term Debt Repaid | - | -1,190 | -787.05 | -312.1 | -18.53 | - | Upgrade
|
| Long-Term Debt Repaid | - | -2.1 | -1.87 | -0.35 | - | - | Upgrade
|
| Total Debt Repaid | -562.61 | -1,192 | -788.92 | -312.45 | -18.53 | - | Upgrade
|
| Net Debt Issued (Repaid) | -472.61 | -559.54 | 776.06 | 602.75 | 244.31 | 18.76 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 416.56 | - | Upgrade
|
| Common Dividends Paid | -132.06 | -68.7 | -123.92 | -102.31 | -1.86 | - | Upgrade
|
| Other Financing Activities | 326.49 | 244.79 | 129.2 | -666.06 | -280.41 | -21.74 | Upgrade
|
| Financing Cash Flow | -278.18 | -383.44 | 781.34 | -165.62 | 378.6 | -2.98 | Upgrade
|
| Foreign Exchange Rate Adjustments | -7.07 | 5.28 | 17.58 | -2.5 | -10.79 | 4.66 | Upgrade
|
| Net Cash Flow | 155.61 | -920.1 | 788.75 | -214.56 | 650.69 | 26 | Upgrade
|
| Free Cash Flow | 9.39 | 150.28 | 22.21 | -101.66 | 509.06 | 42.79 | Upgrade
|
| Free Cash Flow Growth | -93.92% | 576.62% | - | - | 1089.76% | 138.48% | Upgrade
|
| Free Cash Flow Margin | 2.02% | 20.12% | 3.12% | -11.19% | 36.33% | 11.05% | Upgrade
|
| Free Cash Flow Per Share | 0.02 | 0.36 | 0.05 | -0.25 | 1.36 | 0.12 | Upgrade
|
| Cash Income Tax Paid | 43.63 | 34.94 | 9.9 | 60.8 | -31.58 | -4.15 | Upgrade
|
| Levered Free Cash Flow | 105.01 | 71.37 | -46.16 | -97.74 | 281.44 | 58.96 | Upgrade
|
| Unlevered Free Cash Flow | 133.2 | 99.56 | -34.24 | -95.95 | 282.95 | 58.98 | Upgrade
|
| Change in Net Working Capital | -166.94 | -17.54 | 41.22 | 177.94 | 67.58 | -21.62 | Upgrade
|
Updated Oct 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.